EVERY DOSAGE INCLUDES A 4 WEEK SUPPLY Starter - 0.25mg - $199 0.5mg - $249 1mg - $299 1.7mg - $349 2.4mg - $399 TIRZEPATIDE Dual-action GIP and GLP-1 receptor agonist designed to support medically guided weight management by helping regulate appetite, improve satiety, and support metabolic function
The analysis included eight randomized controlled trials with 2,372 participants (all with BMI 27 kg/m) and found that weight regain was proportional to the amount initially lost.48 On average, participants who had taken liraglutide regained 2.2 kg, while those who had taken semaglutide or tirzepatide regained 9.69 kg after stopping the medication.48 Similarly, a 2025 review in Biomolecules showed that patients treated with GLP-1 or dual GLP-1/GIP agonists experience substantial weight loss (ranging from about 6% to over 20%) but also significant weight regain upon drug discontinuation
During the first month, your body is adjusting to reduced calorie intake, lower insulin levels, and changes in how it stores carbohydrates and water
The blend lets researchers examine potential additive or synergistic effects in a single formulation
Unregulated Product Risks Because MT-2 is not FDA-approved for any indication, all available product is unregulated
Tirzepatide addresses the metabolic side of that equation effectively
